论文部分内容阅读
目的:研究分析在慢性阻塞性肺疾病患者的临床治疗中给予维生素D治疗的临床措施和效果,为其临床治疗提供理论依据。方法:回顾性分析2010年5月-2012年6月期间,我院收治的292例慢阻塞性肺疾病患者的临床资料,按照患者入院的时间顺序将292例患者随机分为两组,对照组146例,给予常规临床治疗,观察组患者146例,在常规治疗的基础上给予维生素的辅助治疗。比较两组患者的临床症状情况、痰量和CAT水平。结果:治疗后对照组患者的痰量测定结果和肺功能检查结果有所改善,治疗前后比较差异明显,具有统计学意义,(P<0.05);观察组患者治疗后的痰量测定结果和肺功能检查情况均发生明显改善,与治疗前比较差异明显,具有显著统计学意义,(P<0.01),且观察组患者治疗后的CAT水平显著优于对照组,组间比较存在明显差异,具有统计学意义,(P<0.05)。结论:在慢性阻塞性肺疾病患者的临床治疗中给予维生素D辅助治疗能够有效的改善患者的临床症状,提高治疗效果,减少患者的病程,颇具临床意义,值得临床推广。
OBJECTIVE: To study and analyze the clinical measures and effects of vitamin D therapy in the clinical treatment of patients with chronic obstructive pulmonary disease, and to provide a theoretical basis for its clinical treatment. Methods: The clinical data of 292 patients with COPD admitted in our hospital from May 2010 to June 2012 were retrospectively analyzed. 292 patients were randomly divided into two groups according to their time of admission. The control group 146 cases, given routine clinical treatment, observation group of 146 patients, on the basis of routine treatment given vitamin adjuvant therapy. Clinical symptoms, sputum volume and CAT level were compared between the two groups. Results: After treatment, the sputum quantity and pulmonary function test result of the control group patients were improved. There was significant difference between the two groups before and after treatment (P <0.05). The results of the sputum quantity test and lung (P <0.01). The level of CAT in the observation group was significantly better than that in the control group. There was a significant difference between the two groups and the difference between the two groups was statistically significant Statistical significance (P <0.05). Conclusion: The adjuvant treatment of vitamin D in clinical treatment of patients with chronic obstructive pulmonary disease can effectively improve the clinical symptoms, improve the therapeutic effect and reduce the duration of the disease. It is of clinical significance and worthy of clinical promotion.